← Back to Patent Explorer
US4223038A Expired / Lapsed US ⏱️ 0.0 years remaining

Bicyclic β-lactam antibiotics

Assignee: Beecham Group PLC
•
Filing: 1978-10-30
•
Granted: 1980-09-16
•
Expires: 1998-10-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of the formula (I): ##STR1## wherein G is hydrogen, alkyl, alkenyl, substituted alkyl or substituted alkenyl, R 1 is alkyl or aryl, substituted alkyl or substituted aryl, and R is an organic group such that --CO 2 R is an ester group are produced. The compounds are useful as antibacterial and β-lactamase inhibitory agents.

Inventors

  • 👤 Terence C. Smale

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 00:34
CPC Classifications
C; C07; C07D; C07D477/00; C07D477/10; C07D477/12; C07D477/16; C07D477/20; A; A61; A61P; A61P31/00; A61P31/04; C07D205/00; C07D205/02; C07D205/06; C07D205/08; C07D205/12; C07F; C07F9/00; C07F9/02; C07F9/547; C07F9/553; C07F9/568

Claims Analysis

Total Claims: 56
Claim 1
Independent Claim 107 words
A compound of the formula (I): ##STR118## wherein G is hydrogen, R 1 is alkyl of 1 to 6 carbon atoms unsubstituted or substituted by hydroxy, amino or amino protected by by alkanoyl or 1 to 6 carbon atoms, benzyloxycarbonyl or p-nitrobenzyloxycarbonyl; phenyl unsubstituted or substituted by one or more halogen alkyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, amino or amino protected by alkanoyl of 1 to 6 carbon atoms, benzyloxycarbonyl or p-nitrobenzyloxycarbonyl, and R is alkyl of 1 to 6 carbon atoms, benzyl, p-nitrobenzyl, p-methoxybenzyl phenacyl, p-bromophenacyl, 2,2,2-trichloroethyl, phthalidyl, phthalimidomethyl, α-ethoxycarbonyloxyethyl or alkanoyloxymethyl of 1 to 6 carbon atoms.
Claim 2
Dependent Claim 107 words
A compound of the formula (I): ##STR118## wherein G is hydrogen, R 1 is alkyl of 1 to 6 carbon atoms unsubstituted or substituted by hydroxy, amino or amino protected by by alkanoyl or 1 to 6 carbon atoms, benzyloxycarbonyl or p-nitrobenzyloxycarbonyl; phenyl unsubstituted or substituted by one or more halogen alkyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, amino or amino protected by alkanoyl of 1 to 6 carbon atoms, benzyloxycarbonyl or p-nitrobenzyloxycarbonyl, and R is alkyl of 1 to 6 carbon atoms, benzyl, p-nitrobenzyl, p-methoxybenzyl phenacyl, p-bromophenacyl, 2,2,2-trichloroethyl, phthalidyl, phthalimidomethyl, α-ethoxycarbonyloxyethyl or alkanoyloxymethyl of 1 to 6 carbon atoms.
Claim 3
Dependent Claim 14 words
A compound according to claim 1, wherein R 1 is 2-acetamidoethyl, phenyl or p-acetamidophenyl.
Claim 4
Dependent Claim 12 words
A compound according to claim 1 wherein R 1 is unbranched alkyl.
Claim 5
Dependent Claim 14 words
A compound according to claim 3 wherein R 1 is ethyl, propyl or butyl.
Claim 6
Dependent Claim 24 words
A compound according to claim 1 wherein R 1 is a tertiary alkyl in which the tertiary centre is α to the sulphur atom.
Claim 7
Dependent Claim 13 words
A compound according to claim 5 wherein R 1 is t-butyl or 1,1-dimethylpropyl.
Claim 8
Dependent Claim 30 words
A compound according to claim 1 wherein R is alkyl of 1 to 6 carbon atoms, benzyl, benzyl substituted by nitro or methoxy, phenacyl, phenacyl substituted by bromo or 2,2,2-trichloroethyl.
Claim 9
Dependent Claim 15 words
A compound according to claim 7 wherein R is benzyl, p-nitrobenzyl, p-methoxybenzyl, phenacyl or p-bromophenacyl.
Claim 10
Dependent Claim 15 words
A compound according to claim 1 wherein R is phthalidyl, phthalimidomethyl, α-ethoxycarbonyloxyethyl or lower alkanoyloxymethyl.
Claim 11
Dependent Claim 12 words
A compound according to claim 9 wherein R is pivaloyloxymethyl or acetoxymethyl.
Claim 12
Dependent Claim 10 words
A compound according to claim 1 having the stereochemistry: ##STR119##
Claim 13
Dependent Claim 11 words
A compound according to claim 1 having the relative stereochemistry: ##STR120##
Claim 14
Dependent Claim 11 words
A compound according to claim 1 having the relative stereochemistry ##STR121##
Claim 15
Dependent Claim 37 words
A compound selected from the group consisting of: Methyl 7-oxo-3-ethylsulphinyl-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, Benzyl 7-oxo-3-phenylsulphinyl-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, Benzyl 7-oxo-3-ethylsulphinyl-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, Benzyl 3-acetylaminoethylsulphinyl-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, Benzyl 3-(4'Acetylaminophenyl)sulphinyl-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, Benzyl 3-t-butylsulphinyl-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, Benzyl 3-(2-hydroxyethyl)sulphinyl-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, Benzyl 7-oxo-3-tritylsulphinyl-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, Benzyl 3-nitroethylsulphinyl-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, Benzyl 7-oxo-3-tritylaminoethylsulphinyl-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, 4-Nitrobenzyl 3-ethylsulphinyl-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, 4-Nitrobenzyl 3-acetylaminoethylsulphinyl-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, 4-Nitrobenzyl 7-oxo-3-tritylaminoethylsulphinyl-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, and 4-Nitrobenzyl 3-(4'-nitrobenzyloxycarbonylaminoethylsulphinyl)-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate.
Claim 16
Dependent Claim 37 words
A compound selected from the group consisting of: Methyl 7-oxo-3-ethylsulphinyl-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, Benzyl 7-oxo-3-phenylsulphinyl-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, Benzyl 7-oxo-3-ethylsulphinyl-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, Benzyl 3-acetylaminoethylsulphinyl-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, Benzyl 3-(4'Acetylaminophenyl)sulphinyl-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, Benzyl 3-t-butylsulphinyl-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, Benzyl 3-(2-hydroxyethyl)sulphinyl-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, Benzyl 7-oxo-3-tritylsulphinyl-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, Benzyl 3-nitroethylsulphinyl-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, Benzyl 7-oxo-3-tritylaminoethylsulphinyl-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, 4-Nitrobenzyl 3-ethylsulphinyl-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, 4-Nitrobenzyl 3-acetylaminoethylsulphinyl-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, 4-Nitrobenzyl 7-oxo-3-tritylaminoethylsulphinyl-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, and 4-Nitrobenzyl 3-(4'-nitrobenzyloxycarbonylaminoethylsulphinyl)-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate.
Claim 17
Dependent Claim 124 words
A pharmaceutical composition useful for treating bacterial infections in humans and animals which comprises an antibacterially effective amount of a compound of the formula: ##STR122## wherein G is hydrogen, R 1 is alkyl of 1 to 6 carbon atoms unsubstituted or substituted by hydroxy, amino or amino protected by alkanoyl of 1 to 6 carbon atoms, benzyloxycarbonyl of p-nitrobenzyloxycarbonyl; phenyl unsubstituted or substituted by one or more halogen alkyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, amino or amino protected by alkanoyl of 1 to 6 carbon atoms, benzyloxycarbonyl or p-nitrobenzyloxycarbonyl, and R is alkyl of 1 to 6 carbon atoms, benzyl, p-nitrobenzyl, p-methoxybenzyl, phenacyl, p-bromophenacyl, 2,2,2-trichloroethyl, phthalidyl, phthalimidomethyl, α-ethoxycarbonyloxyethyl or alkanoyloxymethyl of 1 to 6 carbon atoms.
Claim 18
Dependent Claim 124 words
A pharmaceutical composition useful for treating bacterial infections in humans and animals which comprises an antibacterially effective amount of a compound of the formula: ##STR122## wherein G is hydrogen, R 1 is alkyl of 1 to 6 carbon atoms unsubstituted or substituted by hydroxy, amino or amino protected by alkanoyl of 1 to 6 carbon atoms, benzyloxycarbonyl of p-nitrobenzyloxycarbonyl; phenyl unsubstituted or substituted by one or more halogen alkyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, amino or amino protected by alkanoyl of 1 to 6 carbon atoms, benzyloxycarbonyl or p-nitrobenzyloxycarbonyl, and R is alkyl of 1 to 6 carbon atoms, benzyl, p-nitrobenzyl, p-methoxybenzyl, phenacyl, p-bromophenacyl, 2,2,2-trichloroethyl, phthalidyl, phthalimidomethyl, α-ethoxycarbonyloxyethyl or alkanoyloxymethyl of 1 to 6 carbon atoms.
Claim 19
Dependent Claim 14 words
A composition according to claim 15 wherein R 1 is 2-acetamidoethyl, phenyl or p-acetamidophenyl.
Claim 20
Dependent Claim 12 words
A composition according to claim 15 wherein R 1 is unbranched alkyl.
Claim 21
Dependent Claim 14 words
A composition according to claim 17 wherein R 1 is ethyl, propyl or butyl.
Claim 22
Dependent Claim 24 words
A composition according to claim 15 wherein R 1 is a tertiary alkyl in which the tertiary centre is α to the sulphur atom.
Claim 23
Dependent Claim 13 words
A composition according to claim 19 wherein R 1 is t-butyl or 1,1-dimethylpropyl.
Claim 24
Dependent Claim 30 words
A composition according to claim 15 wherein R is alkyl of 1 to 6 carbon atoms, benzyl, benzyl substituted by nitro or methoxy, phenacyl, phenacyl substituted by bromo or 2,2,2-trichloroethyl.
Claim 25
Dependent Claim 15 words
A composition according to claim 21 wherein R is benzyl, p-nitrobenzyl, p-methoxybenzyl, phenacyl or p-bromophenacyl.
Claim 26
Dependent Claim 15 words
A composition according to claim 15 wherein R is phthalidyl, phthalimidomethyl, α-ethoxycarbonyloxyethyl or lower alkanoyloxymethyl.
Claim 27
Dependent Claim 12 words
A composition according to claim 23 wherein R is pivaloyloxymethyl or acetoxymethyl.
Claim 28
Dependent Claim 13 words
A composition according to claim 15 wherein the compound has the stereochemistry: ##STR123##
Claim 29
Dependent Claim 14 words
A composition according to claim 15 wherein the compound has the relative stereochemistry: ##STR124##
Claim 30
Dependent Claim 14 words
A composition according to claim 15 wherein the compound has the relative stereochemistry: ##STR125##
Claim 31
Dependent Claim 10 words
A composition according to claim 15 in oral administration form.
Claim 32
Dependent Claim 10 words
A composition according to claim 15 in parenteral administration form.
Claim 33
Dependent Claim 10 words
A composition according to claim 15 in topical application form.
Claim 34
Dependent Claim 10 words
A composition according to claim 15 in rectal administration form.
Claim 35
Dependent Claim 73 words
A pharmaceutical composition useful for treating bacterial infections in humans and animals which comprises an antibacterially effective amount of a compound selected from the group consisting of: Methyl 7-oxo-3-ethylsulphinyl-1-azabicyclo[3,2,0] hept-2-ene-2-carboxylate, Benzyl 7-oxo-3-phenylsulphinyl-1-azabicyclo[3,2,0] hept-2-ene-2-carboxylate, Benzyl 7-oxo-3-ethylsulphinyl-1-azabicyclo[3,2,0] hept-2-ene-2-carboxylate, Benzyl 3-acetylaminoethylsulphinyl-7-oxo-1-azabicyclo [3,2,0]hept-2-ene-2-carboxylate, Benzyl 3-(4'Acetylaminophenyl)sulphinyl-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, Benzyl 3-t-butylsulphinyl-7-oxo-1-azabicyclo[3,2,0] hept-2-ene-2-carboxylate, Benzyl 3-(2-hydroxyethyl)sulphinyl-7-oxo-1-azabicyclo [3,2,0]hept-2-ene-2-carboxylate, Benzyl 7-oxo-3-tritylsulphinyl-1-azabicyclo[3,2,0] hept-2-ene-2-carboxylate, Benzyl 3-nitroethylsulphinyl-7-oxo-1-azabicyclo[3,2,0] hept-2-ene-2-carboxylate, Benzyl 7-oxo-3-tritylaminoethylsulphinyl-1-azabicyclo [3,2,0]hept-2-ene-2-carboxylate, 4-Nitrobenzyl 3-ethylsulphinyl-7-oxo-1-azabicyclo [3,2,0]hept-2-ene-2-carboxylate, 4-Nitrobenzyl 3-acetylaminoethylsulphinyl-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, 4-Nitrobenzyl 7-oxo-3-tritylaminoethylsulphinyl-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, and 4-Nitrobenzyl 3-(4'nitrobenzyloxycarbonylaminoethylsulphinyl)-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, in combination with a pharmaceutically acceptable carrier.
Claim 36
Dependent Claim 73 words
A pharmaceutical composition useful for treating bacterial infections in humans and animals which comprises an antibacterially effective amount of a compound selected from the group consisting of: Methyl 7-oxo-3-ethylsulphinyl-1-azabicyclo[3,2,0] hept-2-ene-2-carboxylate, Benzyl 7-oxo-3-phenylsulphinyl-1-azabicyclo[3,2,0] hept-2-ene-2-carboxylate, Benzyl 7-oxo-3-ethylsulphinyl-1-azabicyclo[3,2,0] hept-2-ene-2-carboxylate, Benzyl 3-acetylaminoethylsulphinyl-7-oxo-1-azabicyclo [3,2,0]hept-2-ene-2-carboxylate, Benzyl 3-(4'Acetylaminophenyl)sulphinyl-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, Benzyl 3-t-butylsulphinyl-7-oxo-1-azabicyclo[3,2,0] hept-2-ene-2-carboxylate, Benzyl 3-(2-hydroxyethyl)sulphinyl-7-oxo-1-azabicyclo [3,2,0]hept-2-ene-2-carboxylate, Benzyl 7-oxo-3-tritylsulphinyl-1-azabicyclo[3,2,0] hept-2-ene-2-carboxylate, Benzyl 3-nitroethylsulphinyl-7-oxo-1-azabicyclo[3,2,0] hept-2-ene-2-carboxylate, Benzyl 7-oxo-3-tritylaminoethylsulphinyl-1-azabicyclo [3,2,0]hept-2-ene-2-carboxylate, 4-Nitrobenzyl 3-ethylsulphinyl-7-oxo-1-azabicyclo [3,2,0]hept-2-ene-2-carboxylate, 4-Nitrobenzyl 3-acetylaminoethylsulphinyl-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, 4-Nitrobenzyl 7-oxo-3-tritylaminoethylsulphinyl-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, and 4-Nitrobenzyl 3-(4'nitrobenzyloxycarbonylaminoethylsulphinyl)-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, in combination with a pharmaceutically acceptable carrier.
Claim 37
Independent Claim 131 words
A method of treating bacterial infections in humans and animals which comprises administering to a human or animal in need thereof an antibacterially effective amount of a compound of the formula: ##STR126## wherein G is hydrogen, R 1 is alkyl of 1 to 6 carbon atoms unsubstituted or substituted by hydroxy, amino or amino protected by alkanoyl of 1 to 6 carbon atoms, benzyloxycarbonyl or p-nitrobenzyloxycarbonyl; phenyl unsubstituted or substituted by one or more halogen alkyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, amino or amino protected by alkanoyl of 1 to 6 carbon atoms, benzyloxycarbonyl or p-nitrobenzyloxycarbonyl, and R is alkyl of 1 to 6 carbon atoms, benzyl, p-nitrobenzyl, p-methoxybenzyl, phenacyl, p-bromophenacyl, 2,2,2-trichloroethyl, phthalidyl, phthalimidomethyl, α-ethoxycarbonyloxyethyl or alkanoyloxymethyl of 1 to 6 carbon atoms.
Claim 38
Independent Claim 131 words
A method of treating bacterial infections in humans and animals which comprises administering to a human or animal in need thereof an antibacterially effective amount of a compound of the formula: ##STR126## wherein G is hydrogen, R 1 is alkyl of 1 to 6 carbon atoms unsubstituted or substituted by hydroxy, amino or amino protected by alkanoyl of 1 to 6 carbon atoms, benzyloxycarbonyl or p-nitrobenzyloxycarbonyl; phenyl unsubstituted or substituted by one or more halogen alkyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, amino or amino protected by alkanoyl of 1 to 6 carbon atoms, benzyloxycarbonyl or p-nitrobenzyloxycarbonyl, and R is alkyl of 1 to 6 carbon atoms, benzyl, p-nitrobenzyl, p-methoxybenzyl, phenacyl, p-bromophenacyl, 2,2,2-trichloroethyl, phthalidyl, phthalimidomethyl, α-ethoxycarbonyloxyethyl or alkanoyloxymethyl of 1 to 6 carbon atoms.
Claim 39
Dependent Claim 14 words
A method according to claim 33 wherein R 1 is 2-acetamidoethyl, phenyl or p-acetamidophenyl.
Claim 40
Dependent Claim 12 words
A method according to claim 33 wherein R 1 is unbranched alkyl.
Claim 41
Dependent Claim 14 words
A method according to claim 35 wherein R 1 is ethyl, propyl or butyl.
Claim 42
Dependent Claim 24 words
A method according to claim 33 wherein R 1 is a tertiary alkyl in which the tertiary centre is α to the sulphur atom.
Claim 43
Dependent Claim 13 words
A method according to claim 37 wherein R 1 is t-butyl or 1,1-dimethylpropyl.
Claim 44
Dependent Claim 30 words
A method according to claim 33 wherein R is alkyl of 1 to 6 carbon atoms, benzyl, benzyl substituted by nitro or methoxy, phenacyl, phenacyl substituted by bromo, or 2,2,2-trichloroethyl.
Claim 45
Dependent Claim 15 words
A method according to claim 39 wherein R is benzyl, p-nitrobenzyl, p-methoxybenzyl, phenacyl or p-bromophenacyl.
Claim 46
Dependent Claim 15 words
A method according to claim 33 wherein R is phthalidyl, phthalimidomethyl, α-ethoxycarbonyloxyethyl or lower alkanoyloxymethyl.
Claim 47
Dependent Claim 12 words
A method according to claim 41 wherein R is pivaloyloxymethyl or acetoxymethyl.
Claim 48
Dependent Claim 13 words
A method according to claim 33 wherein the compound has the stereochemistry: ##STR127##
Claim 49
Dependent Claim 14 words
A method according to claim 33 wherein the compound has the relative stereochemistry: ##STR128##
Claim 50
Dependent Claim 14 words
A method according to claim 33 wherein the compound has the relative stereochemistry: ##STR129##
Claim 51
Dependent Claim 11 words
A method according to claim 33 wherein the administration is oral.
Claim 52
Dependent Claim 11 words
A method according to claim 33 wherein the administration is parenteral.
Claim 53
Dependent Claim 13 words
A method according to claim 33 wherein the administration is by topical application.
Claim 54
Dependent Claim 11 words
A method according to claim 33 wherein the administration is rectally.
Claim 55
Independent Claim 74 words
A method of treating bacterial infections in humans and animals which comprises administering to a human or animal in need thereof an antibacterially effective amount of a compound selected from the group consisting of: Methyl 7-oxo-3-ethylsulphinyl-1-azabicyclo[3,2,0] hept-2-ene-2-carboxylate, Benzyl 7-oxo-3-phenylsulphinyl-1-azabicyclo[3,2,0] hept-2-ene-2-carboxylate, Benzyl 7-oxo-3-ethylsulphinyl-1-azabicyclo[3,2,0] -hept-2-ene-2-carboxylate, Benzyl 3-acetylaminoethylsulphinyl-7-oxo-1-azabicyclo [3,2,0]hept-2-ene-2-carboxylate, Benzyl 3-(4'Acetylaminophenyl)sulphinyl-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, Benzyl 3-t-butylsulphinyl-7-oxo-1-azabicyclo[3,2,0] hept-2-ene-2-carboxylate, Benzyl 3-(2-hydroxyethyl)sulphinyl-7-oxo-1-azabicyclo [3,2,0]hept-2-ene-2-carboxylate, Benzyl 7-oxo-3-tritylsulphinyl-1-azabicyclo[3,2,0] hept-2-ene-2-carboxylate, Benzyl 3-nitroethylsulphinyl-7-oxo-1-azabicyclo[3,2,0] hept-2-ene-2-carboxylate, Benzyl 7-oxo-3-tritylaminoethylsulphinyl-1-azabicyclo [3,2,0]hept-2-ene-2-carboxylate, 4-Nitrobenzyl 3-ethylsulphinyl-7-oxo-1-azabicyclo [3,2,0]hept-2-ene-2-carboxylate, 4-Nitrobenzyl 3-acetylaminoethylsulphinyl-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, 4-Nitrobenzyl 7-oxo-3-tritylaminoethylsulphinyl-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, and 4-Nitrobenzyl 3-(4'nitrobenzyloxycarbonylaminoethylsulphinyl)-7-oxo-1-azabicyclo[3,2,0] hept-2-ene-2-carboxylate.
Claim 56
Independent Claim 74 words
A method of treating bacterial infections in humans and animals which comprises administering to a human or animal in need thereof an antibacterially effective amount of a compound selected from the group consisting of: Methyl 7-oxo-3-ethylsulphinyl-1-azabicyclo[3,2,0] hept-2-ene-2-carboxylate, Benzyl 7-oxo-3-phenylsulphinyl-1-azabicyclo[3,2,0] hept-2-ene-2-carboxylate, Benzyl 7-oxo-3-ethylsulphinyl-1-azabicyclo[3,2,0] -hept-2-ene-2-carboxylate, Benzyl 3-acetylaminoethylsulphinyl-7-oxo-1-azabicyclo [3,2,0]hept-2-ene-2-carboxylate, Benzyl 3-(4'Acetylaminophenyl)sulphinyl-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, Benzyl 3-t-butylsulphinyl-7-oxo-1-azabicyclo[3,2,0] hept-2-ene-2-carboxylate, Benzyl 3-(2-hydroxyethyl)sulphinyl-7-oxo-1-azabicyclo [3,2,0]hept-2-ene-2-carboxylate, Benzyl 7-oxo-3-tritylsulphinyl-1-azabicyclo[3,2,0] hept-2-ene-2-carboxylate, Benzyl 3-nitroethylsulphinyl-7-oxo-1-azabicyclo[3,2,0] hept-2-ene-2-carboxylate, Benzyl 7-oxo-3-tritylaminoethylsulphinyl-1-azabicyclo [3,2,0]hept-2-ene-2-carboxylate, 4-Nitrobenzyl 3-ethylsulphinyl-7-oxo-1-azabicyclo [3,2,0]hept-2-ene-2-carboxylate, 4-Nitrobenzyl 3-acetylaminoethylsulphinyl-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, 4-Nitrobenzyl 7-oxo-3-tritylaminoethylsulphinyl-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate, and 4-Nitrobenzyl 3-(4'nitrobenzyloxycarbonylaminoethylsulphinyl)-7-oxo-1-azabicyclo[3,2,0] hept-2-ene-2-carboxylate.

References Cited (Backward Citations)

US4123547A Cited
US4150145A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-09-16 1984-03-17 1984-09-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-09-16 1988-03-17 1988-09-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-09-16 1992-03-17 1992-09-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag